Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) Rose 0.22% to 13.520

Newtimespace News, as of 13:26 on May 20, Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) was quoted at HKD 13.520, up 0.22%. The ETF opened at HKD 13.510, with a high of HKD 13.630 and a low of HKD 13.400. The latest Net Asset Value (NAV) per unit is HKD 13.534, with a premium rate of -0.32%. The asset size is approximately HKD 2.101 billion.

Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) tracks the Hang Seng Biotechnology Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to measure and track the overall performance of the 30 largest biotechnology companies listed on The Stock Exchange of Hong Kong that are eligible for Stock Connect trading. The index focuses on core biotechnology areas such as innovative drugs, CXO, medical devices, and services. It provides investors with a high-purity tool for concentrated investment in leading Hong Kong-listed biotechnology companies and capturing innovation and development opportunities in the healthcare industry.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.